Skip to content

HPHARMA: what changed

BE 0680.620.492NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€18,505
2024 · €21,471-€2,966
Equity
€264,577
2024 · €246,071+€18,505
Cash
€90,363
2024 · €87,101+€3,261
Balance sheet total
€789,401
2024 · €777,852+€11,548

Largest movements

2024 to 2025
Assets
  • Deferred charges and accrued income -€62,611

    down €62,611 (-98.5%), from €63,591 to €979

  • Tangible fixed assets +€36,144

    up €36,144 (+10.3%), from €349,245 to €385,389

    of which Furniture and vehicles: +€55,865

  • Receivables within one year +€34,790

    up €34,790 (+47.3%), from €73,516 to €108,306

    of which Trade receivables: +€46,364

  • Current investments +€23,085

    up €23,085 (+231%), from €10,007 to €33,092

  • Intangible fixed assets -€22,239

    down €22,239 (-38.0%), from €58,540 to €36,301

Equity and liabilities
  • Trade debts +€46,941

    up €46,941 (+44.0%), from €106,598 to €153,539

  • Debts after one year -€41,535

    down €41,535 (-13.6%), from €305,957 to €264,422

  • Profit (loss) carried forward +€18,505

    up €18,505 (+12.7%), from €145,640 to €164,146

  • Current portion of long-term debt -€14,208

    down €14,208 (-14.9%), from €95,399 to €81,191

Income statement
  • Staff costs -€82,406

    down €82,406 (-99.8%), from €82,542 to €136

  • Gross operating margin -€75,454

    down €75,454 (-39.4%), from €191,513 to €116,058

  • Depreciation +€13,014

    up €13,014 (+26.9%), from €48,421 to €61,434

  • Financial charges -€4,399

    down €4,399 (-26.6%), from €16,557 to €12,158

  • Write-downs +€2,738

    up €2,738 (+26.7%), from €10,241 to €12,978

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €21,471
Gross operating margin -€75,454
Staff costs +€82,406
Depreciation -€13,014
Write-downs -€2,738
Other operating charges +€263
Financial income -€168
Financial charges +€4,399
Taxes +€1,340
Result 2025 €18,505
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€157,429
Investment -€98,424
Financing -€55,743
Cash 2024 €87,101
Net result for the year +€18,505
Depreciation +€61,434
Stocks and contracts +€882
Receivables within one year -€34,790
Deferred charges and accrued income +€62,611
Trade debts +€46,941
Tax, wage and social debts +€3,924
Other debts -€2,079
Investment in fixed assets (net) -€75,339
Current investments -€23,085
Debts after one year -€41,535
Current portion of long-term debt -€14,208
Cash 2025 €90,363
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €777,852 €789,401 +€11,548 +1.5%
Fixed assets 21/28 €407,785 €421,690 +€13,905 +3.4%
Intangible fixed assets 21 €58,540 €36,301 -€22,239 -38.0%
Tangible fixed assets 22/27 €349,245 €385,389 +€36,144 +10.3%
Land and buildings 22 €297,741 €281,982 -€15,759 -5.3%
Plant, machinery and equipment 23 €46,625 €42,662 -€3,962 -8.5%
Furniture and vehicles 24 €4,879 €60,744 +€55,865 +1,145%
Current assets 29/58 €370,067 €367,711 -€2,356 -0.6%
Stocks and contracts in progress 3 €135,853 €134,971 -€882 -0.6%
Stocks 30/36 €135,853 €134,971 -€882 -0.6%
Amounts receivable within one year 40/41 €73,516 €108,306 +€34,790 +47.3%
Trade receivables 40 €56,634 €102,998 +€46,364 +81.9%
Other amounts receivable 41 €16,882 €5,308 -€11,575 -68.6%
Current investments 50/53 €10,007 €33,092 +€23,085 +231%
Cash at bank and in hand 54/58 €87,101 €90,363 +€3,261 +3.7%
Deferred charges and accrued income 490/1 €63,591 €979 -€62,611 -98.5%
Total equity and liabilities 10/49 €777,852 €789,401 +€11,548 +1.5%
Equity 10/15 €246,071 €264,577 +€18,505 +7.5%
Contributions 10/11 €46,500 €46,500 = 0.0%
Reserves 13 €53,931 €53,931 = 0.0%
Non-distributable reserves 130/1 €531 €531 = 0.0%
Reserves not available under the articles 1311 €531 €531 = 0.0%
Tax-exempt reserves 132 €53,400 €53,400 = 0.0%
Profit (loss) carried forward 14 €145,640 €164,146 +€18,505 +12.7%
Amounts payable 17/49 €531,781 €524,824 -€6,957 -1.3%
Amounts payable after more than one year 17 €305,957 €264,422 -€41,535 -13.6%
Financial debts 170/4 €305,957 €264,422 -€41,535 -13.6%
Amounts payable within one year 42/48 €225,824 €260,402 +€34,578 +15.3%
Current portion of amounts payable after more than one year 42 €95,399 €81,191 -€14,208 -14.9%
Trade debts 44 €106,598 €153,539 +€46,941 +44.0%
Suppliers 440/4 €106,598 €153,539 +€46,941 +44.0%
Taxes, remuneration and social security 45 €2,834 €6,757 +€3,924 +138%
Taxes 450/3 - €6,757 +€6,757
Remuneration and social security 454/9 €2,834 - -€2,834
Other amounts payable 47/48 €20,993 €18,914 -€2,079 -9.9%
Remuneration, social security and pensions 62 €82,542 €136 -€82,406 -99.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €48,421 €61,434 +€13,014 +26.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €10,241 €12,978 +€2,738 +26.7%
Other operating charges 640/8 €5,289 €5,025 -€263 -5.0%
Gross operating margin 9900 €191,513 €116,058 -€75,454 -39.4%
Operating profit (loss) 9901 €45,020 €36,484 -€8,536 -19.0%
Financial income 75/76B €1,105 €936 -€168 -15.2%
Recurring financial income 75 €1,105 €936 -€168 -15.2%
Financial charges 65/66B €16,557 €12,158 -€4,399 -26.6%
Recurring financial charges 65 €16,557 €12,158 -€4,399 -26.6%
Profit (loss) for the period before taxes 9903 €29,568 €25,263 -€4,306 -14.6%
Income taxes 67/77 €8,097 €6,757 -€1,340 -16.5%
Profit (loss) for the period 9904 €21,471 €18,505 -€2,966 -13.8%
Profit (loss) for the period to be appropriated 9905 €21,471 €18,505 -€2,966 -13.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€135,659 to €144,268

Midpoint €139,246 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €228,276
Capitalised earnings €43,043 to €60,260
Indication €135,659 to €144,268

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€264,577
Intangible fixed assets (21)
-€36,301
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€228,276

Capitalised earnings

net result for the year (9904)
2025
€18,505
2024
€21,471
2023
-€29,574
excluding non-recurring income and charges
-€21,900
2022
€26,938
excluding non-recurring income and charges
€23,635
2021
€87,129
Average result, excluding non-recurring income and charges
€6,026
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€43,043 / €50,217 / €60,260

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.